Randomized Phase III Trial of Stereotactic Radiosurgery (SRS) Versus Observation for Patients With Asymptomatic Cerebral Oligo-metastases in Non-small Cell Lung Cancer (NSCLC)
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Overall survival
36 months
No
Myungju Ahn, M.D., Ph.D.
Principal Investigator
Samsung Medical Center
Korea: Food and Drug Administration
2009-01-059
NCT01130766
June 2008
Name | Location |
---|